Ginkgo Bioworks Hldgs Inc (DNA)
13.41 x 1 13.72 x 1
Post-market by (Cboe BZX)
13.55 +1.23 (+9.98%) 02/13/25 [NYSE]
13.41 x 1 13.72 x 1
Post-market 13.60 +0.05 (+0.37%) 19:38 ET
for Thu, Feb 13th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Cash Flows From Operating Activities | |||||
Net Income | -892,869 | -2,106,372 | -1,836,642 | -126,723 | -119,857 |
Depreciation Amortization | 71,554 | 44,423 | 29,076 | 13,864 | 10,755 |
Income taxes - deferred | -801 | -14,609 | N/A | N/A | N/A |
Accounts receivable | 50,068 | 55,024 | -114,094 | -14,228 | -1,843 |
Accounts payable and accrued liabilities | -1,183 | -10,844 | -2,247 | 7,019 | 664 |
Other Working Capital | 29,837 | -37,006 | -61,537 | -26,515 | 10,577 |
Other Operating Activity | 447,894 | 1,817,186 | 1,731,626 | 10,753 | 55,041 |
Operating Cash Flow | $-295,500 | $-252,198 | $-253,818 | $-135,830 | $-44,663 |
Cash Flows From Investing Activities | |||||
PPE Investments | -36,373 | -52,271 | -56,521 | -57,821 | -22,219 |
Net Acquisitions | N/A | 74,728 | -12,040 | N/A | N/A |
Purchase Of Investment | N/A | -3,691 | -5,000 | N/A | -50,133 |
Other Investing Activity | -44,320 | -86,160 | 304 | -9,300 | -2,250 |
Investing Cash Flow | $-80,693 | $-67,394 | $-73,257 | $-67,121 | $-74,602 |
Cash Flows From Financing Activities | |||||
Debt Repayment | -1,295 | -1,237 | -1,123 | -748 | -352 |
Common Stock Issued | 93 | 99,543 | 167 | 26 | 7 |
Common Stock Repurchased | N/A | N/A | -24,998 | N/A | -408 |
Other Financing Activity | -2,014 | -2,969 | 1,560,099 | 91,040 | 411,138 |
Financing Cash Flow | $-3,216 | $95,337 | $1,534,145 | $90,318 | $410,385 |
Exchange Rate Effect | -588 | 908 | -19 | N/A | N/A |
Beginning Cash Position | 1,369,581 | 1,592,928 | 385,877 | 498,510 | 207,390 |
End Cash Position | 989,584 | 1,369,581 | 1,592,928 | 385,877 | 498,510 |
Net Cash Flow | $-379,997 | $-223,347 | $1,207,051 | $-112,633 | $291,120 |
Free Cash Flow | |||||
Operating Cash Flow | -295,500 | -252,198 | -253,818 | -135,830 | -44,663 |
Capital Expenditure | -40,801 | -52,271 | -56,521 | -57,821 | -22,219 |
Free Cash Flow | -336,301 | -304,469 | -310,339 | -193,651 | -66,882 |